China
· Delayed Price · Currency is CNY Sunshine Guojian Pharmaceutical (Shanghai) Company Description
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China.
Its products include YISAIPU, a tumor necrosis factor inhibitor type II-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Septin, an initututab for injection; and Xenipax, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation, as well as used in conjunction with conventional immunosuppression regimens to increase the survival rate of transplanted organs and enhance patients' quality of life.
The company is also developing products for autoimmune, oncology, ophthalmological, and other diseases.
The company was founded in 2002 and is based in Shanghai, China.
| Country | China |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 995 |
| CEO | Yanli Liu |
Contact Details
Address: No. 399, Libing Road Shanghai, 201203 China | |
| Phone | 86 21 8029 7777 |
| Website | 3s-guojian.com |
Stock Details
| Ticker Symbol | 688336 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000062X2 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yanli Liu | GM and Director |